The acute stress response, colloquially referred to as the fight-or-flight response, initiates with a burst of sympathetic nervous system (SNS) activity resulting in elevated catecholaminergic signaling. β-adrenergic receptors (β-ARs) on cardiomyocytes transmit SNS activity into elevated cardiac output. The L-type calcium channel complex (LTCC) is an initial proximal effector of β-AR activation in the myocardium. Catecholaminergic activation of β-ARs results in increased Ca 2+ current through the LTCC (I Ca,L ) with channel activation occurring at lower membrane voltage. The net effect is increased I Ca,L , resulting in accentuated excitation-contraction coupling in the ventricle and faster spontaneous depolarization in the sinoatrial node, thus contributing to increased contraction and faster heart rate, respectively. This increased I Ca,L by β-AR signaling is commonly called modulation. Despite the central physiological importance of Ca V 1.2 modulation combined with extensive investigations to uncover molecular mechanisms of action, we still don't know how the LTCC is modulated.
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The LTCC is a heteromultimeric protein complex. In the myocardium, Ca V 1.2 is the major pore-forming subunit. In older literature, this has been called the α-subunit. An additional array of proteins directly and/or indirectly complex with Ca V 1.2 (1). Ca V β, specifically Ca V β 2 in the heart, is a critical auxiliary protein (2) . For heterologous expression systems, coexpression of α-and β-subunits is necessary and sufficient to recapitulate a near-native I Ca,L ; however, it has not been possible to reproduce Ca V 1.2 modulation in heterologous systems (3) . One interpretation is that key accessory proteins required for modulation are not present in heterologous expression systems. Regardless, the ability of Ca V β to increase Ca V 1.2 trafficking in heterologous expression systems, and to modify Ca V 1.2 gating underscores the central contribution of Ca V α-Ca V β interactions for LTCC function (4) . The linker between repeat segments I and II on Ca V 1.2 contains a so-called α-interaction domain (AID) that confers a biochemically stable complex between Ca V 1.2 and Ca V β 2 . Thus, first principles suggest that the α-β subunit interaction predominates interactions among a sea of multiple proteins that comprise the LTCC complex.
Decades of study unequivocally support active protein kinase A (PKA) as the link from β-AR activation to Ca V 1.2 modulation (5). PKA is a kinase, thus spurring the search for substrate sites within the LTCC that might be critical to transduce Ca V 1.2 modulation. In this edition of the JCI, Yang et al. continue to exploit a clever experimental system to reveal more of what we still don't know about Ca V 1.2 modulation (6). They introduce a transgene in mice to overexpress a Ca V 1.2 construct containing a dihydropyridine-insensitive mutation. This so-called pseudo-WT (pWT) channel is transcriptionally activated from a tetracycline-inducible promoter to allow limited temporal overexpression of Ca V 1.2 in the myocardium. The use of nisoldipine then allows dissection of transgene driven from endogenous I Ca,L . As long as there are no rapid remodeling events in the heart, then outcomes can be interpreted as occurring in healthy ventricular cardiomyocytes. By adding mutations onto the Ca V 1.2-AID, the authors were able to interrogate adult ventricular cardiomyocyte I Ca,L carried by mutant Ca V 1.2. The outcomes using this transgenic strategy are unexpected and quite frankly, surprising.
Are all known PKA substrate phosphor-serine residues dispensable for modulation?
Apparently, the brief answer to the above posed question is simply, yes. Studies of single established Ca V 1.2 PKA-mediated phosphorylation sites eliminated the requirement for Ca V 1.2 sites Ser1928 (7), Ser1700, and Thr1704 (8) , whereas channel complexes in caveolin-3 contribute to signaling Ca 2+ (17). In cells from failing hearts, channel complexes dislocate to the sarcolemma surface, which could promote arrhythmias and contribute to the pathophysiology of heart failure (18). In this vein, it would be interesting to determine whether Ca V β is dispensable for compartment-specific trafficking such as might be altered during pathological remodeling.
Conclusions
Assuming that the transgenic system employed by Yang et al. recapitulates native LTCC complexes with high fidelity leads us to two broad conclusions that require reevaluation of mechanisms of modulation and LTCC cell biology. First, the necessity of an α-β interaction for I Ca,L modulation without an identifiable PKA substrate site suggests the novel idea that signal transduction from PKA activation to I Ca,L modulation requires key protein-protein interactions. This does not obviate the earlier pervasive notion that Ca V β: dispensable for trafficking? Ca V 1.2 forward trafficking dogma holds that Ca v β promotes localizing Ca V 1.2 to surface membrane (4) . Early studies based on heterologous systems demonstrated that the β subunit acts as a chaperone for Ca V 1.2 to exit the Golgi complex and stabilizes channel complexes once in the membrane (13-15). More recent work, also in heterologous expression systems, attributes forward trafficking function to α-β interaction (16). By contrast in this issue of the JCI, Yang et al. show that subcellular localization of Ca V 1.2 was unaffected and peak Ca 2+ currents increased when I Ca,L was measured from LTCC with Ca V 1.2-AID-mutant channels (6) . In other words, the assumption is that forward trafficking was unaffected under conditions whereby α-β interaction could not occur. A reasonable interpretation is that α-β is dispensable for forward trafficking in cardiomyocytes (Figure 1 ). There are, however, some idiosyncrasies in this innovative approach. For example, pseudo-WT and AID-mutant Ca V 1.2 cardiomyocytes display a smaller percentage of contraction compared with that of nontransgenic cardiomyocytes, even though pWT and AID have increased Ca 2+ currents. It is clear that Ca V 1.2 AID mutants can trigger excitation-contraction coupling, but latest work using Ca V 1.2-AID mutations to prevent α-β interaction convincingly demonstrates a requirement for α-β interaction to confer I Ca,L modulation. This suggests that modulation via key protein-protein interactions, rather than one or more phosphoregulatory sites on Ca V 1.2 or Ca V β 2 are involved (Figure 1) . If no known phosphorylation events are identifiable as mechanisms of modulation, then which protein interactions confer a modulated I Ca,L ? Moreover, why are Ca V 1.2-Ser1928 and -Ser1701 conserved and phosphorylated by PKA? It is hard to understand what selection pressure exists to conserve the utilization of these sites across species. One speculative explanation might hold that nonmyocardial I Ca,L modulation has differential mechanisms of modulation. For example, Ser1928 is essential for β 2 -AR signaling in neurons (11) and vascular smooth muscle (12). Application of Yang et al.'s transgene system in noncardiomyocytes would be an interesting test of the hypothesis that Ca V 1.2 phosphor-serine site conservation is attributable to essential nonmyocardial modulation mechanisms. Then the implication is that the LTCC heteromultimeric complex constituents differ across tissues. 
